Legal & General Group PLC Macrogenics Inc Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Macrogenics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 6,452 shares of MGNX stock, worth $21,033. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,452

Previous 6,452 -0.0%

Holding current value

$21,033

Previous $21,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.0 - $5.55 $148,953 - $275,563	-49,651 Reduced 88.5%	6,452 $21,000
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $14,305 - $80,000	4,322 Added 8.35%	56,103 $238,000
Q1 2024 Jul 01, 2024	BUY	$9.77 - $21.47 $45,919 - $100,909	4,700 Added 9.98%	51,781 $762,000
Q1 2024 May 14, 2024	BUY	$9.77 - $21.47 $367,586 - $807,787	37,624 Added 397.84%	47,081 $693,000
Q4 2023 Feb 15, 2024	BUY	$4.48 - $10.11 $6,083 - $13,729	1,358 Added 16.77%	9,457 $90,000
Q3 2023 Nov 14, 2023	SELL	$4.48 - $6.19 $3,552 - $4,908	-793 Reduced 8.92%	8,099 $37,000
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $14,525 - $23,705	3,144 Added 54.7%	8,892 $47,000
Q4 2022 Feb 14, 2023	SELL	$3.34 - $6.98 $38,119 - $79,662	-11,413 Reduced 66.51%	5,748 $38,000
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $388 - $673	129 Added 0.76%	17,161 $60,000
Q2 2022 Aug 22, 2022	SELL	$2.25 - $9.99 $9,405 - $41,758	-4,180 Reduced 19.71%	17,032 $50,000
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $105 - $219	-13 Reduced 0.06%	21,212 $187,000
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $12,027 - $16,541	756 Added 3.69%	21,225 $340,000
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $183,503 - $266,795	9,296 Added 83.2%	20,469 $429,000
Q2 2021 Aug 12, 2021	BUY	$20.49 - $35.63 $31,575 - $54,905	1,541 Added 16.0%	11,173 $300,000
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $4,443 - $7,768	234 Added 2.49%	9,632 $307,000
Q4 2020 Feb 12, 2021	BUY	$19.41 - $26.0 $2,756 - $3,692	142 Added 1.53%	9,398 $215,000
Q3 2020 Nov 13, 2020	SELL	$24.69 - $31.6 $39,750 - $50,876	-1,610 Reduced 14.82%	9,256 $234,000
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $2,849 - $15,957	548 Added 5.31%	10,866 $304,000
Q1 2020 May 14, 2020	SELL	$4.28 - $12.11 $7,181 - $20,320	-1,678 Reduced 13.99%	10,318 $60,000
Q4 2019 Feb 13, 2020	BUY	$7.95 - $12.27 $6,948 - $10,723	874 Added 7.86%	11,996 $131,000
Q3 2019 Nov 13, 2019	BUY	$12.44 - $17.48 $25,663 - $36,061	2,063 Added 22.77%	11,122 $141,000
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $23,607 - $32,068	1,627 Added 21.89%	9,059 $154,000
Q4 2018 Feb 15, 2019	BUY	$11.75 - $21.42 $14,816 - $27,010	1,261 Added 20.43%	7,432 $94,000
Q2 2018 Aug 10, 2018	SELL	$19.78 - $24.67 $6,151 - $7,672	-311 Reduced 4.8%	6,171 $128,000
Q1 2018 May 17, 2018	SELL	$18.89 - $32.46 $47,300 - $81,279	-2,504 Reduced 27.87%	6,482 $163,000
Q4 2017 Feb 13, 2018	BUY	$16.19 - $20.3 $145,483 - $182,415	8,986	8,986 $171,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Macrogenics Inc Transaction History